← Evidence map

ArticleJAMA network open2026

Reporting and Publication of Postmarket Clinical Trials for Novel Drugs Approved by the FDA.

Maximilian Siebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42490115